Caitlin E. Mills

2.4k total citations
22 papers, 609 citations indexed

About

Caitlin E. Mills is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Caitlin E. Mills has authored 22 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Caitlin E. Mills's work include Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and Advanced Breast Cancer Therapies (4 papers). Caitlin E. Mills is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (5 papers) and Advanced Breast Cancer Therapies (4 papers). Caitlin E. Mills collaborates with scholars based in United States, Canada and Germany. Caitlin E. Mills's co-authors include Peter K. Sorger, Mirra Chung, Nathanael S. Gray, Kartik Subramanian, Marc Hafner, Sarah A. Boswell, Robert A. Everley, Changchang Liu, Dejan Juric and Chen Chen and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Caitlin E. Mills

22 papers receiving 602 citations

Peers

Countries citing papers authored by Caitlin E. Mills

Since Specialization

Citations

This map shows the geographic impact of Caitlin E. Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caitlin E. Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caitlin E. Mills more than expected).

Fields of papers citing papers by Caitlin E. Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caitlin E. Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caitlin E. Mills. The network helps show where Caitlin E. Mills may publish in the future.

Co-authorship network of co-authors of Caitlin E. Mills

This figure shows the co-authorship network connecting the top 25 collaborators of Caitlin E. Mills. A scholar is included among the top collaborators of Caitlin E. Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caitlin E. Mills. Caitlin E. Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7) 2024 ·European Journal of Medicinal Chemistry ·(unknown), Guangyan Du, Jie Jiang, Wenchao Lu, Caitlin E. Mills, Linjie Yuan, Fen Jiang, Zhixiang He, Gary A. Bradshaw, Mirra Chung, (unknown), Woong Sub Byun, Stephen M. Hinshaw, Tinghu Zhang, Nathanael S. Gray	1
2	Paired evaluation of machine-learning models characterizes effects of confounders and outliers 2023 ·Patterns ·Maulik K. Nariya, Caitlin E. Mills, Peter K. Sorger, Artem Sokolov	2
3	Proteomic profiling across breast cancer cell lines and models 2023 ·Scientific Data ·Marian Kalocsay, Matthew J. Berberich, Robert A. Everley, Maulik K. Nariya, Mirra Chung, Benjamin L. Gaudio, (unknown), Gary A. Bradshaw, (unknown), Marc Hafner, Peter K. Sorger, Caitlin E. Mills, Kartik Subramanian	6
4	Temporal and spatial topography of cell proliferation in cancer 2022 ·Nature Cell Biology ·Giorgio Gaglia, Sheheryar Kabraji, (unknown), Yang Dai, (unknown), Shu Wang, Caitlin E. Mills, Mirra Chung, Johann S. Bergholz, Shannon Coy, Jia‐Ren Lin, Rinath Jeselsohn, Otto Metzger, Eric P. Winer, Deborah Dillon, Jean J. Zhao, Peter K. Sorger, Sandro Santagata	31
5	Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes 2022 ·eLife ·Laura M. Doherty, Caitlin E. Mills, Sarah A. Boswell, Xiaoxi Liu, Charles Tapley Hoyt, Benjamin M. Gyori, Sara J. Buhrlage, Peter K. Sorger	26
6	Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop 2022 ·Nature Communications ·Caitlin E. Mills, Kartik Subramanian, Marc Hafner, Mario Niepel, Luca Gerosa, Mirra Chung, (unknown), Benjamin L. Gaudio, Clarence Yapp, Ajit J. Nirmal, Nicholas A. Clark, Peter K. Sorger	17
7	Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1 -Deficient Cells 2021 ·Cancer Research ·Anniina Färkkilä, Alfredo Rodríguez, Jaana Oikkonen, D. Gulhan, Huy Nguyen, (unknown), (unknown), Caitlin E. Mills, Fernando Pérez‐Villatoro, Jean‐Bernard Lazaro, Jia Zhou, Connor S. Clairmont, Lisa A. Moreau, Peter J. Park, Peter K. Sorger, Sampsa Hautaniemi, Sara Frı́as, Alan D. D’Andrea	19
8	Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing 2020 ·Cell chemical biology ·Yan Liu, Fleur M. Ferguson, Lianbo Li, Miljan Kuljanin, Caitlin E. Mills, Kartik Subramanian, Wayne Harshbarger, Sudershan Reddy Gondi, Jinhua Wang, Peter K. Sorger, Joseph D. Mancias, Nathanael S. Gray, Kenneth D. Westover	15
9	Development of CDK2 and CDK5 Dual Degrader TMX‐2172 2020 ·Angewandte Chemie International Edition ·Mingxing Teng, Jie Jiang, Zhixiang He, Nicholas Kwiatkowski, Katherine A. Donovan, Caitlin E. Mills, (unknown), John M. Hatcher, Eric S. Fischer, Peter K. Sorger, Tinghu Zhang, Nathanael S. Gray	57
10	Development and Characterization of a Wee1 Kinase Degrader 2019 ·Cell chemical biology ·Zhengnian Li, Benika J. Pinch, (unknown), Katherine A. Donovan, Radosław P. Nowak, Caitlin E. Mills, David A. Scott, Zainab M. Doctor, Nicholas A. Eleuteri, Mirra Chung, Peter K. Sorger, Eric S. Fischer, Nathanael S. Gray	67
11	Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells 2019 ·Cell Systems ·(unknown), (unknown), Adam C. Palmer, Mario Niepel, Mirra Chung, Caitlin E. Mills, (unknown), Qingsong Liu, Jia-Yun Chen, Clarence Yapp, John M. Asara, Nathanael S. Gray, Peter K. Sorger	24
12	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity 2019 ·Cell chemical biology ·Marc Hafner, Caitlin E. Mills, Kartik Subramanian, Chen Chen, Mirra Chung, Sarah A. Boswell, Robert A. Everley, Changchang Liu, Charlotte S. Walmsley, Dejan Juric, Peter K. Sorger	162
13	DeepDyeDrop: an image-based approach to quantify the phenotypic response of cancer cells to therapeutics (Conference Presentation) 2018 ·Marc Hafner, Caitlin E. Mills, Luca Gerosa, Mirra Chung, Mario Niepel, Peter K. Sorger	1
14	Omics profiling of CDK4/6 inhibitors reveals functionally important secondary targets of abemaciclib (Conference Presentation) 2018 ·Caitlin E. Mills, Marc Hafner, Kartik Subramanian, Chen Chen, Sarah A. Boswell, Robert A. Everley, Dejan Juric, Peter K. Sorger	2
15	Multi-Omics Profiling Establishes the Polypharmacology of FDA Approved CSK4/6 Inhibitors and Its Impact on Drug Response 2018 ·SSRN Electronic Journal ·Marc Hafner, Caitlin E. Mills, Kartik Subramanian, Chen Chen, Mirra Chung, Sarah A. Boswell, Robert A. Everley, Changchang Liu, Charlotte S. Walmsley, Dejan Juric, Peter K. Sorger	1
16	A mouse-human phase I co-clinical trial of taselisib in combination with TDM1 in advanced HER2-positive breast cancer (MBC). 2017 ·Journal of Clinical Oncology ·Otto Metzger, Shom Goel, William T. Barry, Erika Hamilton, Sara M. Tolaney, Denise A. Yardley, (unknown), Michelle K. DeMeo, Caitlin E. Mills, Marc Hafner, Eric P. Winer, Jean J. Zhao, Ian E. Krop	11
17	Abstract 203: Single cell imaging of kinase inhibitor-induced effects in breast cancer cell lines 2016 ·Cancer Research ·Caitlin E. Mills, David W. Andrews, Peter K. Sorger	1
18	The Relative Biological Effectiveness of Low-Dose Mammography Quality X Rays in the Human Breast MCF-10A Cell Line 2014 ·Radiation Research ·Caitlin E. Mills, Christopher Thome, David Koff, David W. Andrews, Douglas R. Boreham	9
19	Human Health and the Biological Effects of Tritium in Drinking Water: Prudent Policy through Science – Addressing the ODWAC New Recommendation 2011 ·Dose-Response ·Steve Dingwall, Caitlin E. Mills, (unknown), (unknown), Douglas R. Boreham	24
20	A cloverleaf detector system for in vivo bone lead measurement 2007 ·Medical Physics ·David Fleming, Caitlin E. Mills	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact